Activity 1 - University of Florida Optimizing Disease Management (ODM) A Vision for Diabetic Eye Screening


Loading - Please Wait

Activity 2 - University of Florida Optimizing Disease Management (ODM) A Vision for Diabetic Eye Screening: Do It Better


Loading - Please Wait

Jointly provided by University of Florida and DKBmed in collaboration with Postgraduate Institute for Medicine.
Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Between 40% and 45% of Americans with diabetes have some stage of diabetic retinopathy, but only ~50% are aware that they have it.

Diabetic retinopathy is the leading cause of blindness in working-age adults and affects four of every ten people with diabetes. But only half of those who should be screened for diabetic retinopathy are screened, leaving the rest vulnerable to vision loss that is frequently not detected until it is too late. Timely treatment of diabetic retinopathy can reduce the risk of vision loss by 95%.

Now, primary care clinicians can screen their patients with diabetes using an AI-assisted diagnostic camera. Images are also securely sent to an ophthalmologist who will overread the images for other eye conditions. Optimizing Disease Management (ODM): Diabetic Retinopathy, a University of Florida Health quality improvement initiative, provides primary care clinicians with the tools to detect diabetic retinopathy in patients who may not otherwise be screened.

Start / Register

Faculty

Sonal Tuli, MD, MEd Sonal Tuli, MD, MEd
Professor and Chair,
Department of Ophthalmology,
University of Florida College of Medicine

Sonal S. Tuli, MD, MEd, completed her residency in ophthalmology at Indiana University in 2000. She completed her fellowship in cornea and external diseases at the Bascom Palmer Eye Institute in Miami, Florida, and joined the University of Florida Department of Ophthalmology in 2001. She also completed a master’s degree in education in 2012 at UF. Dr. Tuli was appointed interim chair of the department in October 2013 and named chair in April 2015. Dr. Tuli is board-certified in ophthalmology. Her interests include cataracts, corneal transplants, ocular surface cancers, dry eye disease and infectious eye diseases. She provides adult and family-based ophthalmic care. Dr. Tuli was appointed director of the division of cornea and external diseases in 2003 and has also directed its fellowship program since 2003. At the national level, Dr. Tuli is Vice-chair of the Practicing Ophthalmologists Curriculum Committee and just completed a term as the Chair of the Online Education Committee and the AAO educational representative to the Continuing Medical Education Task Force. She was invited and has served as an oral examiner for the American Board of Ophthalmology since 2006.


Peter Carek, MD, MS Peter Carek, MD, MS
Professor and Chair
Department of Community Health and Family Medicine,
University of Florida College of Medicine

Peter J. Carek, MD, MS is professor and chair in the Department of Community Health and Family Medicine at the University of Florida as well as holds the C. Sue and Louis C. Murray, M.D. Professor in Family Medicine. Dr. Carek attended medical school at the Medical University of South Carolina (MUSC) in Charleston, SC where he also completed his family medicine residency training. He completed a fellowship in sports medicine at the Ohio Physical Therapy and Sports Medicine Clinic and the University of Tennessee Medical Center in Knoxville. He served as director of the Trident/MUSC Family Medicine Residency Program from 1995 to 2012. He is a Fellow of the American Academy of Family Physicians (AAFP) and a Diplomate of the American Board of Family Medicine (ABFM). Dr. Carek also holds a Certificate of Added Qualification (CAQ) in Primary Care Sports Medicine. Dr. Carek has authored/co-authored over 95 articles for peer-reviewed journals as well as over 30 chapters, monographs and articles for non-peered reviewed journals and has presented over 130 invited presentations and over 95 submitted presentations during meetings of national and international medical organizations.


Marika Alois, MD, FAAFP
Assistant Professor
Division of General Internal Medicine,
UF Health Integrative Medicine Program
University of Florida College of Medicine

Marika Alois, MD is a faculty member within the division of general internal medicine, serving as a physician for both integrative medicine and internal medicine for primary care services. Dr. Alois received her medical degree from Georgetown University, during which she served as an intern at The Center for Mind-Body Medicine. She then went on to complete her residency training at Beth Israel Medical Center in family medicine and her fellowship training in integrative medicine. She participated in the Foundations in Herbal Medicine longitudinal training with Dr. Tieraona Low Dog while completing her fellowship.


John Malaty, MD, FAAFP John Malaty, MD, FAAFP
John Malaty, MD, FAAFP
Associate Professor
Medical Director – Family Medicine at Main Street Clinic
Director – Resident as Teacher Program
Associate Program Director
Community Health and Family Medicine
University of Florida

Dr. Malaty received his M.D. from the University of Florida and his B.S. in Biology from Binghamton University, New York. After graduating from Binghamton, Dr. Malaty performed cancer research for 2 years at UF, where he graduated with Honors in Research in 2004. He completed an internship in general surgery and 2 years of ENT training at UF, prior to pursuing Family Medicine.

CME/CE

Accreditation

Medicine

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Florida Gainseville College of Medicine and DKBmed. The University of Florida Gainseville College of Medicine is accredited by the ACCME to provide continuation medical education for physicians.

The University of Florida Gainseville College of Medicine designates each enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Florida Gainseville College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACCME Competencies

  • Medical Knowledge
JPA

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, the University of Florida Gainseville, and DKBmed, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The AAFP has reviewed Optimizing Disease Management: A Vision for Diabetic Eye Screening at the University of Florida, and deemed it acceptable for AAFP credit. Term of approval is from 11/01/2020 to 10/31/2021. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session(s):

  • 0.50 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – University of Florida Optimizing Disease Management (ODM) A Vision for Diabetic Eye Screening
  • 0.50 Enduring Materials, Self-Study AAFP Prescribed Credit(s) – University of Florida Optimizing Disease Management (ODM) A Vision for Diabetic Eye Screening: Do It Better

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Target Audience

This activity is intended for health care professionals and social workers involved with the management or treatment of patients with type 2 diabetes.

Educational Support

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Planners and Managers

Planning committee members from the University of Florida, Laura Gruber, MBA, MHS, Rasa Williamson, and Serena Ugarte have nothing to disclose.

The PIM planners and managers have nothing to disclose.

The following DKB planners and managers Dean Beals, Stan Pogroszewski, Rachel Deerr, Ashleigh Winter, and Lesley Simon, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

PIM
UF Health

The program is jointly provided by the University of Florida Gainesville College of Medicine and DKBmed in collaboration with Postgraduate Institute for Medicine.

Estimated time to complete each activity: 1.0 hours

Media

Internet

DKBmed

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Activity 1 release date: 9/20/2020

Activity 1 expiration date: 9/19/2022

Activity 2 release date: xx/xx/xx

Activity 2 release date: xx/xx/xx